euromuscular blocking/stimulation in cerebral palsy
Not Applicable
- Conditions
- Cerebral palsy.Cerebral palsy
- Registration Number
- IRCT20200215046504N1
- Lead Sponsor
- Prince Sattam bin Abdulaziz University/Deanship of Scientific Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Diagnosis of spastic hemiplegic cerebral palsy
age between 6 and 10 years
Spasticity grade II or III according to Modified Ashworth Scale
mental capacity enabling compliance with evaluation and treatment instructions
Normal/corrected visual and auditory function
Exclusion Criteria
Contractures limiting arm-hand function
Botulinum toxin-A injection in the involved upper limb in the past six months
If children will be advised against stopping spasticity-relieving medications during the study period by their neuro-pediatrician
Orthopedic or neuromuscular surgery or casting of the paretic upper limb within 1 year before starting study
Uncontrolled seizures
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nilateral upper-limb function. Timepoint: Pre-treatment, post-treatment, and 6 months after treatment (all completed). Method of measurement: Melbourne Assessment.;Bimanual hand function. Timepoint: Pre-treatment, post-treatment, and 6 months after treatment (all completed). Method of measurement: Assisting Hand Assessment.
- Secondary Outcome Measures
Name Time Method Arm-hand, real-time function. Timepoint: Pre-treatment, Post-treatment, and 6 months post-treatment (all completed). Method of measurement: Pediatric Motor Activity Log.